Prospective randomized phase II study of FOLFIRI versus FOLFOX7 in advanced gastric adenocarcinoma: a Chinese Western Cooperative Gastrointestinal Oncology Group Study

Until now, no standard chemotherapy has been widely accepted for advanced gastric cancer (GC). The current research aimed to compare folinic acid, fluorouracil with irinotecan (mFOLFIRI) or with oxaliplatin (mFOLFOX7) as first-line treatments in patients with locally advanced GC in an open, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiu, Wen, Feng, Zhou, Chengya, Qiu, Meng, Liu, Jiyan, Chen, Jing, Yi, Cheng, Li, Zhiping, Luo, Deyun, Xu, Feng, Cai, Xiaohong, Bi, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716699/
https://www.ncbi.nlm.nih.gov/pubmed/29228659
http://dx.doi.org/10.18632/oncotarget.18426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716699/
https://www.ncbi.nlm.nih.gov/pubmed/29228659
http://dx.doi.org/10.18632/oncotarget.18426

Ejemplares similares